These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27709465)

  • 21. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of leukotriene receptor antagonists (LTRAs) in the management of asthma.
    Haughney J
    Scott Med J; 1999 Apr; 44(2):37-8. PubMed ID: 10370978
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in the management of asthma associated with smoking-induced airway diseases.
    Thomson NC
    Expert Opin Pharmacother; 2018 Oct; 19(14):1565-1579. PubMed ID: 30196731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
    Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
    N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
    Barnes PJ
    J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
    Albertson TE; Chenoweth JA; Adams JY; Sutter ME
    Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of inhaled corticosteroids and leukotriene receptor antagonists in adolescents and adults with mild to moderate asthma: a meta-analysis.
    Yang D; Luo H; Wang J; Bunjhoo H; Xu Y; Xiong W
    Clin Respir J; 2013 Jan; 7(1):74-90. PubMed ID: 22364111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principal findings of systematic reviews for chronic treatment in childhood asthma.
    Castro-Rodriguez JA; Rodrigo GJ; Rodriguez-Martinez CE
    J Asthma; 2015 May; 52(4):407-16. PubMed ID: 25275887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions.
    Wurst KE; St Laurent S; Hinds D; Davis KJ
    COPD; 2017 Apr; 14(2):200-209. PubMed ID: 28103123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.
    Sadatsafavi M; Lynd L; Marra C; Bedouch P; Fitzgerald M
    J Allergy Clin Immunol; 2013 Jul; 132(1):63-9. PubMed ID: 23545274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antileukotrienes in asthma - critical view].
    Droszcz W
    Pneumonol Alergol Pol; 2010; 78(1):60-7. PubMed ID: 20162520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
    Dorais M; Blais L; Chabot I; LeLorier J
    J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.